Study Shows How to Better Predict Pacemaker Needs in Myotonic Dystrophy Patients

A recent study has examined what risk factors exist for patients diagnosed with myotonic dystrophy, the most common of all muscular dystrophies. This is a progressive, hereditary condition. Regarding cardiac…

Continue Reading Study Shows How to Better Predict Pacemaker Needs in Myotonic Dystrophy Patients
FDA Rejects CKD Drug Tenapanor
Photo by Paweł Czerwiński on Unsplash

FDA Rejects CKD Drug Tenapanor

Despite drug developers' best efforts, the path to approval is not always easy. Ask biotechnology company Ardelyx, whose potential treatment option tenapanor was recently rejected by the FDA. According to…

Continue Reading FDA Rejects CKD Drug Tenapanor
A Plethora of Treatment Options Brings Hope To Relapsed/Refractory Follicular Lymphoma Patients
source: pixabay.com

A Plethora of Treatment Options Brings Hope To Relapsed/Refractory Follicular Lymphoma Patients

Dr. Javier Munoz, the director of the Mayo Clinic's Lymphoma program in Phoenix, has recently conducted an interview with Kristie Kahl, the Vice President of content for the Cancer Network.…

Continue Reading A Plethora of Treatment Options Brings Hope To Relapsed/Refractory Follicular Lymphoma Patients
Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients
source: pixabay.com

Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients

A Phase 3 clinical trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma in patients where it was previously untreated have just announced they are still recruiting participants. The trial is…

Continue Reading Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients